+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Accelerating Impact for Hard-to-Treat Cancers Award

Children's Cancer Research Fund

This award supports basic, clinical, and population studies focused on hard-to-treat cancers where treatment success has remained out of reach. Projects may include pilot and feasibility studies, secondary analysis of existing data, small, self-contained research projects, development of new methodology, and development of new research technology. A Hard-to-Treat Award is $250,000 for a two-year period. Children’s Cancer Research Fund defines hard-to-treat cancer as 5-year survival of less than 70% in an individual cancer (e.g. osteosarcoma, AML, DIPG), in a cancer with unfavorable behavior (e.g. relapse or metastasis), or in a molecular defined subtype (e.g. MLL rearranged leukemia, PAX3-FOXO1 rearranged RMS). Cancer with survival <70% in demographic groups defined by age, sex, or race/ethnicity may also qualify if a biological hypothesis is being pursued.

AI Based Application Success Predictor

1. Alignment with CCRF’s Focus Areas

CCRF targets research in hard‑to‑treat pediatric cancers, survivorship, and health disparities—especially projects addressing cancers with <70% survival or inequities in care .
Best predictor: proposal directly matches one of these themes.

🧪 2. Innovation & Seeding Impactful Research

CCRF prioritizes pilot/feasibility studies that serve as springboards for larger federal or foundation funding .
Recommendation: Focus on bold, proof‑of‑concept studies with translational value.

📊 3. Strong Study Design & Feasibility

As peer-reviewed by their Research Advisory Committee, successful proposals demonstrate:

Clear hypotheses and methods

Appropriate sample sizes and feasibility

Preplanned evaluation metrics and milestones

Value for money and justified budgets

🤝 4. Institutional and Collaborative Support

Letters from mentor(s) or institutional leaders indicate readiness to execute the work. Multicenter or interdisciplinary partnerships—especially for hard-to-treat categories—add credibility .

👩‍👧‍👦 5. Patient-Centered & Equity Focus

For survivorship and disparities awards, applications that include patient perspectives—especially from underserved communities—stand out .

📈 6. Proof of Track Record & Growth

Even though CCRF supports emerging investigators, having preliminary data, relevant experience, or a track record of publication boosts competitiveness .

📝 7. Peer-Review Process

Applications undergo peer review by multiple experts, including Pediatric Oncology researchers, with feedback provided—indicating the importance of strong science and expert endorsement .

🧩 Summary Table

Predictor	What It Means
Theme alignment	Matches CCRF’s 3 focus areas
Pilot translational design	Feasible, innovative seed studies
Solid methodology	Clear aims, methods, metrics
Institutional support	Letters, partnerships, resources
Patient centricity & EDI	Embedded in project design
Demonstrated capacity	Pilot data and investigator experience
Peer review fit	Strong scientific endorsement

💡 Tips to Strengthen Your Application

Select the relevant award—whether hard-to-treat, survivorship, or disparities.

Frame as a pilot that scales—outline how it will lead to bigger grants.

Validate methods—include power calculations, endpoints, and contingency plans.

Secure strong endorsement—get institutional letters and confirm IRB/logistics alignment.

Include patient voices—public/patient engagement and underserved focus matters.

Leverage preliminary data—even small datasets or pilot observations help reassure reviewers.

Highlight next steps—show how funding will catalyze continued progress.

Specialties

Cancer

Pediatrics

Oncology

Eligibility Requirements

• Applicants must be PI-eligible at their sponsoring institution

• Awardees are required to commit at least 10 percent of their research effort each year to activities supported by this award

• Applicant U.S. citizenship is not a requirement

• Applications will be accepted only from U.S. based institutions

Sponsor Details

Sponsor Institute/Organizations: Children's Cancer Research Fund

Sponsor Type: Corporate/Non-Profit

Address: 1650 W 82nd St., Suite 400 Minneapolis, MN 55431

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity